Novavax Inc (NVAX) Stock Price, Quote & News

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 268 2000

Website: www.novavax.com

Address:

21 Firstfield Road, Gaithersburg, United States

chloeworld5 Jul. 15 at 6:43 PM

$NVAX FYI Sk Bioscience sold 1 million shares of nvax after the Sanofi deal.

0 · Reply

Flowdollas777 Jul. 15 at 6:42 PM

$NVAX If it wasn't the Matrix M in my bag...i'd be worried. It's not the product thats the problem. Paytience longs! Our payday is coming.....sooner or later. Sanofi can't stall much longer imho. 😁👑 🌎💪🏽💉#MatrixM #Boom

0 · Reply

ejaXstoXX Jul. 15 at 6:39 PM

$NVAX

0 · Reply

ejaXstoXX Jul. 15 at 6:35 PM

$NVAX could be worse, imagine if jacobs wasn’t excited.

0 · Reply

Pissed_of_retards2 Jul. 15 at 6:34 PM

$NVAX really horrible terrible game of nerves (except for management supplied with millions no matter what is on the chart). yet logical would be if the price moved within 5 months on combo news. and / or within 1 year on onco news. if both happens there could be also buyout offers from pfizer sanofi and lilly next year but for how much. hopefully at least 40. i even forgot the shah floor price how is the time passing. but that was before pfe deal and more onco mtas.

0 · Reply

Hoodoo_Voodoo Jul. 15 at 5:46 PM

$NVAX remember when SK Bio bought at 13 😆 Don’t feel bad!

1 · Reply

DrSammy Jul. 15 at 5:41 PM

$NVAX A close friend of mine Asked me this morning : Would you pay Baltimore these salaries and bonuses for what they've done?/accomplished I said, I'd double their pays but structure it differently :)

0 · Reply

DrSammy Jul. 15 at 5:30 PM

$NVAX Sometimes markets create Opportunities -- take advantage of them! It'll cost Billion$ to create and build Approved/Safe Technology Platforms & Major BPs are interested in -- Majority of those who 'try' fail! Accomplishments are extraordinary!

2 · Reply

Paulchowda Jul. 15 at 5:27 PM

$NVAX guess what I’m not doing yep, that’s right… I needed one more fucking number for at least 125-135k I guess I’m having a hungry man turkey dinner tonight…

1 · Reply

OneDollarBob Jul. 15 at 5:08 PM

$NVAX I have a hard time believing Novavax management is not involved in this constant manipulation in some way. They simply refuse to do or say anything that might have a positive impact on the share price.

2 · Reply

Novavax put volume heavy and directionally bearish

Jun 24, 2026, 8:00 AM EDT - 21 days ago

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

2026-06-22T15:15:08.000Z - 23 days ago

Novavax put volume heavy and directionally bearish

Jun 18, 2026, 8:30 AM EDT - 27 days ago

Novavax Transcript: AGM 2026

Jun 4, 2026, 10:30 AM EDT - 5 weeks ago

Novavax Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 4:00 PM EDT - 6 weeks ago

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

May 13, 2026, 6:40 PM EDT - 2 months ago

Novavax Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 7:00 AM EDT - 2 months ago

Novavax Slides: Corporate presentation

May 11, 2026, 7:53 AM EDT - 2 months ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO MRNA

May 7, 2026, 4:00 PM EDT - 2 months ago

Novavax to Participate in BofA Securities 2026 Health Care Conference

2026-05-07T06:32:47.000Z - 2 months ago

Novavax reports Q1 EPS (6c), consensus (23c)

2026-05-07T05:08:24.000Z - 2 months ago

Novavax price target raised to $9 from $8 at TD Cowen

SNY

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Novavax Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

May 6, 2026, 7:56 AM EDT - 2 months ago

Novavax beats first-quarter revenue estimates on vaccine deals strength

Apr 29, 2026, 4:00 PM EDT - 2 months ago

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Novavax Proxy statement: Proxy filing

2026-04-09T14:00:15.000Z - 3 months ago

Novavax price target raised to $18 from $16 at B. Riley

Apr 8, 2026, 6:08 AM EDT - 3 months ago

Shah Capital intends to vote against Novavax's board nominees, executive compensation

Mar 30, 2026, 8:00 AM EDT - 3 months ago

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Mar 10, 2026, 3:40 PM EDT - 4 months ago

Novavax Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 2:30 PM EST - 4 months ago

Novavax Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 4:30 PM EST - 4 months ago

Novavax to Participate in Upcoming Investor Conferences

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 4 months ago

Novavax Slides: Q4 2025

Feb 26, 2026, 8:06 AM EST - 4 months ago

Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals

Feb 26, 2026, 8:00 AM EST - 4 months ago

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Feb 19, 2026, 8:00 AM EST - 5 months ago

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Jan 20, 2026, 7:15 AM EST - 6 months ago

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:11 AM EST - 6 months ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Jan 14, 2026, 7:30 PM EST - 6 months ago

Novavax Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 6 months ago

Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 6 months ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 1, 2025, 3:50 PM EST - 8 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Dec 1, 2025, 12:35 PM EST - 8 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Dec 1, 2025, 9:59 AM EST - 8 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Nov 19, 2025, 11:30 AM EST - 8 months ago

Novavax Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 4:41 PM EST - 8 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 8:00 AM EST - 8 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

Novavax Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 7:58 AM EST - 8 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 4, 2025, 7:00 AM EST - 9 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Oct 30, 2025, 8:00 AM EDT - 9 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 22, 2025, 7:00 AM EDT - 9 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 14, 2025, 6:09 AM EDT - 9 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 7, 2025, 7:00 AM EDT - 10 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Sep 30, 2025, 9:01 AM EDT - 10 months ago

Novavax Announces Progress on Sanofi Agreement

Sep 19, 2025, 11:40 AM EDT - 10 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Sep 4, 2025, 10:20 AM EDT - 11 months ago

Novavax Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 11 months ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 3, 2025, 8:00 AM EDT - 11 months ago

Novavax to Participate in the Cantor Global Healthcare Conference

Aug 27, 2025, 3:07 PM EDT - 11 months ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 21, 2025, 7:43 AM EDT - 11 months ago

Novavax Announces Convertible Debt Refinancing

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Slides: Q2 2025

Aug 6, 2025, 8:08 AM EDT - 1 year ago

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Slides: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 7:11 AM EDT - 1 year ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 10, 2025, 10:45 AM EDT - 1 year ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Jun 10, 2025, 9:30 AM EDT - 1 year ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Jun 10, 2025, 8:18 AM EDT - 1 year ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

May 20, 2025, 4:34 PM EDT - 1 year ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 19, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

May 19, 2025, 9:27 AM EDT - 1 year ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 7:16 AM EDT - 1 year ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

May 19, 2025, 7:00 AM EDT - 1 year ago

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine

May 17, 2025, 10:26 PM EDT - 1 year ago

FDA approves Novavax COVID vaccine with new conditions

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 6:00 PM EDT - 1 year ago

Novavax Slides: FY 2025

May 8, 2025, 11:12 AM EDT - 1 year ago

Why This Shrinking Covid-19 Vaccine Stock Jumped 30%

chloeworld5 Jul. 15 at 6:43 PM

$NVAX FYI Sk Bioscience sold 1 million shares of nvax after the Sanofi deal.

0 · Reply

Flowdollas777 Jul. 15 at 6:42 PM

0 · Reply

ejaXstoXX Jul. 15 at 6:39 PM

$NVAX

0 · Reply

ejaXstoXX Jul. 15 at 6:35 PM

$NVAX could be worse, imagine if jacobs wasn’t excited.

0 · Reply

Pissed_of_retards2 Jul. 15 at 6:34 PM

0 · Reply

Hoodoo_Voodoo Jul. 15 at 5:46 PM

$NVAX remember when SK Bio bought at 13 😆 Don’t feel bad!

1 · Reply

DrSammy Jul. 15 at 5:41 PM

0 · Reply

DrSammy Jul. 15 at 5:30 PM

2 · Reply

Paulchowda Jul. 15 at 5:27 PM

$NVAX guess what I’m not doing yep, that’s right… I needed one more fucking number for at least 125-135k I guess I’m having a hungry man turkey dinner tonight…

1 · Reply

OneDollarBob Jul. 15 at 5:08 PM

2 · Reply

inapick Jul. 15 at 5:07 PM

$NVAX

0 · Reply

Hoodoo_Voodoo Jul. 15 at 4:39 PM

$NVAX I believe Framus had this going to 7.79 if I recall… 5s after that. Great stuff Jacobs.

0 · Reply

amnlla Jul. 15 at 4:25 PM

$NVAX This stupid stock just won’t stop falling. There’s no way the company can succeed with JJ around. The nerve of them… they want bonuses for their failures.

1 · Reply

ejaXstoXX Jul. 15 at 4:21 PM

$NVAX Another fireside chat. I need more excitement.

1 · Reply

Trader00995 Jul. 15 at 4:17 PM

$NVAX $8.11

1 · Reply

chloeworld5 Jul. 15 at 4:13 PM

$NVAX positive mta conversations? Positive sanofi conversations? Keep talking!

0 · Reply

Flo6 Jul. 15 at 4:08 PM

$NVAX why red again?!

2 · Reply

LUKAN88 Jul. 15 at 3:55 PM

$NVAX ARE YOU TALKING ABOUT YOURSELF?

0 · Reply

Ivan_the_Great Jul. 15 at 3:54 PM

$NVAX Unrelated to Novavax but some big names, especially in tech, taking massive beatings in their valuations. Sundisk, IBM, Micron, Intel, etc. Meanwhile everyone is still cheering for AI and its success…. Is this the making of another bubble? History would tell us so.

1 · Reply

DenaliLife Jul. 15 at 3:42 PM

$NVAX Someone’s definitely loading.

0 · Reply

Hoodoo_Voodoo Jul. 15 at 3:40 PM

$NVAX definitely going lower

1 · Reply

xxtpat Jul. 15 at 3:21 PM

$NVAX I suppose I’ll be blocking users quite liberally here too. Otherwise, the Novavax section becomes impossible to read properly. I’m happy to read criticism of my shares, but not baseless rubbish that adds no value. It just obscures the essential posts.

0 · Reply

Market Cap	1.47B
Revenue (ttm)	1.12B
Net Income (ttm)	440.30M
EPS (ttm)	N/A
PE Ratio	186.60
Forward PE	N/A
Profit Margin	39.19%
Debt to Equity Ratio	-2.01

Volume	1,497,611
Avg Vol	5,312,682
Day's Range	N/A - N/A
Shares Out	164.44M
Stochastic %K	0%
Beta	2.43
Analysts	Sell
Price Target	$13.80